Extra-respiratory manifestations of COVID-19
Authors:
- 1 August 2020
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 56 (2) , 106024
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewearBritish Journal of Ophthalmology, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Going Viral 2019Dermatologic Clinics, 2019
- Serious Neurological Adverse Events after Ivermectin—Do They Occur beyond the Indication of Onchocerciasis?The American Journal of Tropical Medicine and Hygiene, 2018
- The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous systemThe Journal of Pathology, 2014
- Interleukin‐6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease‐modifying antirheumatic drugs: The tocilizumab in combination with traditional disease‐modifying antirheumatic drug therapy studyArthritis & Rheumatism, 2008
- Angiotensin II and Its Receptor Subtypes in the Human RetinaInvestigative Ophthalmology & Visual Science, 2007
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system.British Journal of Ophthalmology, 1996